84 related articles for article (PubMed ID: 21338239)
1. NDRG2 expression regulates CD24 and metastatic potential of breast cancer cells.
Zheng J; Liu Q; Li Y; Yang J; Ma J; Yu F; Shi H; Ren Q; Zhang R; Zhang J; Xue Y; Tao Y; Jiang N; Guo H; Yao L; Liu W
Asian Pac J Cancer Prev; 2010; 11(6):1817-21. PubMed ID: 21338239
[TBL] [Abstract][Full Text] [Related]
2. CD24 enhances DNA damage-induced apoptosis by modulating NF-κB signaling in CD44-expressing breast cancer cells.
Ju JH; Jang K; Lee KM; Kim M; Kim J; Yi JY; Noh DY; Shin I
Carcinogenesis; 2011 Oct; 32(10):1474-83. PubMed ID: 21798852
[TBL] [Abstract][Full Text] [Related]
3. Combined aberrant expression of N-Myc downstream-regulated gene 2 and CD24 is associated with disease-free survival and overall survival in patients with hepatocellular carcinoma.
Li B; Shao Q; Ji D; Li F; Guo X; Chen G
Diagn Pathol; 2014 Oct; 9():209. PubMed ID: 25338637
[TBL] [Abstract][Full Text] [Related]
4. HES1-mediated inhibition of Notch1 signaling by a Gemini vitamin D analog leads to decreased CD44(+)/CD24(-/low) tumor-initiating subpopulation in basal-like breast cancer.
So JY; Wahler J; Das Gupta S; Salerno DM; Maehr H; Uskokovic M; Suh N
J Steroid Biochem Mol Biol; 2015 Apr; 148():111-21. PubMed ID: 25541438
[TBL] [Abstract][Full Text] [Related]
5. NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression.
Zheng J; Li Y; Yang J; Liu Q; Shi M; Zhang R; Shi H; Ren Q; Ma J; Guo H; Tao Y; Xue Y; Jiang N; Yao L; Liu W
BMC Cancer; 2011 Jun; 11():251:1-9. PubMed ID: 21676268
[TBL] [Abstract][Full Text] [Related]
6. Tumor-suppressive effect of adenovirus-mediated inhibitor of growth 4 gene transfer in breast carcinoma cells in vitro and in vivo.
Li Z; Xie Y; Sheng W; Miao J; Xiang J; Yang J
Cancer Biother Radiopharm; 2010 Aug; 25(4):427-37. PubMed ID: 20707719
[TBL] [Abstract][Full Text] [Related]
7. NDRG2 controls COX-2/PGE₂-mediated breast cancer cell migration and invasion.
Kim MJ; Kim HS; Lee SH; Yang Y; Lee MS; Lim JS
Mol Cells; 2014 Oct; 37(10):759-65. PubMed ID: 25256221
[TBL] [Abstract][Full Text] [Related]
8. Targeting of COX-2 expression by recombinant adenovirus shRNA attenuates the malignant biological behavior of breast cancer cells.
Tu B; Ma TT; Peng XQ; Wang Q; Yang H; Huang XL
Asian Pac J Cancer Prev; 2014; 15(20):8829-36. PubMed ID: 25374215
[TBL] [Abstract][Full Text] [Related]
9. NDRG2 suppresses the proliferation of clear cell renal cell carcinoma cell A-498.
Ma JJ; Liao CG; Jiang X; Zhao HD; Yao LB; Bao TY
J Exp Clin Cancer Res; 2010 Jul; 29(1):103. PubMed ID: 20673333
[TBL] [Abstract][Full Text] [Related]
10. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
[TBL] [Abstract][Full Text] [Related]
11. Isolation of CD24(high) and CD24(low/-) cells from MCF-7: CD24 expression is positively related with proliferation, adhesion and invasion in MCF-7.
Kim HJ; Kim JB; Lee KM; Shin I; Han W; Ko E; Bae JY; Noh DY
Cancer Lett; 2007 Dec; 258(1):98-108. PubMed ID: 17950993
[TBL] [Abstract][Full Text] [Related]
12. Adenovirus siMDM2 and NDRG2 Gene Therapy Inhibits Cell Proliferation and Induces Apoptosis of Squamous Cell Carcinoma.
Wang S; Chen N; Dong N; Lu L; Liu L; Zhang L
Cell Biochem Biophys; 2015 Nov; 73(2):513-518. PubMed ID: 27352346
[TBL] [Abstract][Full Text] [Related]
13. The Hedgehog signaling pathway plays an essential role in maintaining the CD44+CD24-/low subpopulation and the side population of breast cancer cells.
Tanaka H; Nakamura M; Kameda C; Kubo M; Sato N; Kuroki S; Tanaka M; Katano M
Anticancer Res; 2009 Jun; 29(6):2147-57. PubMed ID: 19528475
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of Efp by DNA-modified small interfering RNA inhibits breast cancer cell proliferation and in vivo tumor growth.
Ueyama K; Ikeda K; Sato W; Nakasato N; Horie-Inoue K; Takeda S; Inoue S
Cancer Gene Ther; 2010 Sep; 17(9):624-32. PubMed ID: 20467453
[TBL] [Abstract][Full Text] [Related]
15. Abundant NDRG2 Expression Is Associated with Aggressiveness and Unfavorable Patients' Outcome in Basal-Like Breast Cancer.
Kloten V; Schlensog M; Eschenbruch J; Gasthaus J; Tiedemann J; Mijnes J; Heide T; Braunschweig T; Knüchel R; Dahl E
PLoS One; 2016; 11(7):e0159073. PubMed ID: 27400234
[TBL] [Abstract][Full Text] [Related]
16. N‑Myc downstream‑regulated gene 2 suppresses the proliferation of T24 human bladder cancer cells via induction of oncosis.
Huang J; Wu Z; Wang G; Cai Y; Cai M; Li Y
Mol Med Rep; 2015 Oct; 12(4):5730-6. PubMed ID: 26239274
[TBL] [Abstract][Full Text] [Related]
17. NDRG2 is highly expressed in pancreatic beta cells and involved in protection against lipotoxicity.
Shen L; Liu X; Hou W; Yang G; Wu Y; Zhang R; Li X; Che H; Lu Z; Zhang Y; Liu X; Yao L
Cell Mol Life Sci; 2010 Apr; 67(8):1371-81. PubMed ID: 20127388
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-9 is associated with epithelial-mesenchymal transition, breast cancer stem cell phenotype, and tumor progression in breast cancer.
Gwak JM; Kim HJ; Kim EJ; Chung YR; Yun S; Seo AN; Lee HJ; Park SY
Breast Cancer Res Treat; 2014 Aug; 147(1):39-49. PubMed ID: 25086633
[TBL] [Abstract][Full Text] [Related]
20. TOB suppresses breast cancer tumorigenesis.
O'Malley S; Su H; Zhang T; Ng C; Ge H; Tang CK
Int J Cancer; 2009 Oct; 125(8):1805-13. PubMed ID: 19569230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]